» Articles » PMID: 28990104

Antiangiogenic Properties of Caudatin In vitro and In vivo by Suppression of VEGF‑VEGFR2‑AKT/FAK Signal Axis

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2017 Oct 10
PMID 28990104
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor angiogenesis provides essential nutrients and oxygen to the tumor microenvironment, which is important in tumor growth, progression and metastasis. Inhibition of tumor angiogenesis represents one of the most promising strategies in tumor therapy. The authors previously demonstrated that caudatin, one species of C‑21 steroidal from Cynanchum auriculatum (C. auriculatum), effectively inhibits human glioma growth in vitro and in vivo through triggering cell cycle arrest and apoptosis. However, little information regarding the antiangiogenic properties of caudatin in human glioma is available. Based on the author's previous study, the antiangiogenic effect of caudatin against human glioma was explored, and the underlying mechanism was investigated. The results suggested that caudatin treatment significantly inhibited HUVEC human umbilical vein endothelial cell proliferation, blocked the HUVECs migration, invasion and capillary‑like tube formation by disturbing the vascular endothelial growth factor (VEGF)‑VEGFR2‑protein kinase B (AKT)/focal adhesion kinase (FAK) signal axis. Notably, caudatin treatment abolished the glioma cell growth by suppression of the in vivo angiogenesis, which involved FAK and AKT dephosphorylation and inhibition of VEGF expression. The findings validated the antiangiogenic potential of caudatin in hunting human glioma.

Citing Articles

Caudatin Inhibits the Proliferation, Invasion, and Glycolysis of Osteosarcoma Cells via the Wnt/- Catenin Pathway.

Zhang Y, Sheng Z, Su C, Xia Y, Chen X, Huang X Evid Based Complement Alternat Med. 2023; 2022:4026688.

PMID: 36588592 PMC: 9803569. DOI: 10.1155/2022/4026688.


Royle ex Wight., Decne. and (Maxim.) Hemsl.: Current Research and Prospects.

Wang L, Cai F, Zhao W, Tian J, Kong D, Sun X Molecules. 2021; 26(23).

PMID: 34885647 PMC: 8658831. DOI: 10.3390/molecules26237065.


Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors.

Ma J, Ren J, Thorikay M, van Dinther M, Sanchez-Duffhues G, Caradec J Cancers (Basel). 2021; 13(12).

PMID: 34204675 PMC: 8231556. DOI: 10.3390/cancers13122951.


Anticancer effect of caudatin in diethylnitrosamine‑induced hepatocarcinogenesis in rats.

Song J, Ding W, Liu B, Liu D, Xia Z, Zhang L Mol Med Rep. 2020; 22(2):697-706.

PMID: 32626931 PMC: 7339819. DOI: 10.3892/mmr.2020.11135.


Overexpression of Limb-Bud and Heart (LBH) promotes angiogenesis in human glioma via VEGFA-mediated ERK signalling under hypoxia.

Jiang Y, Zhou J, Zou D, Hou D, Zhang H, Zhao J EBioMedicine. 2019; 48:36-48.

PMID: 31631037 PMC: 6838451. DOI: 10.1016/j.ebiom.2019.09.037.


References
1.
Shen T, Park A, Alcaraz A, Peng X, Jang I, Koni P . Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J Cell Biol. 2005; 169(6):941-52. PMC: 2171636. DOI: 10.1083/jcb.200411155. View

2.
Wang Y, Yang B, Zhang R, Wei E . [Inhibitive effect of C-21 steroidal glycosides of Cynanchum auriculatum on rat glioma cells in vitro]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011; 40(4):402-7. DOI: 10.3785/j.issn.1008-9292.2011.04.010. View

3.
Berz D, Wanebo H . Targeting the growth factors and angiogenesis pathways: small molecules in solid tumors. J Surg Oncol. 2011; 103(6):574-86. DOI: 10.1002/jso.21776. View

4.
Luo Y, Sun Z, Li Y, Liu L, Cai X, Li Z . Caudatin inhibits human hepatoma cell growth and metastasis through modulation of the Wnt/β-catenin pathway. Oncol Rep. 2013; 30(6):2923-8. DOI: 10.3892/or.2013.2749. View

5.
Pyun B, Choi S, Lee Y, Kim T, Min J, Kim Y . Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity. Cancer Res. 2008; 68(1):227-35. DOI: 10.1158/0008-5472.CAN-07-2799. View